San Francisco-based RentJuice, a provider of software enabling property managers and real estate brokers to manage rental listings, announced today that it bought Boston-based competitor Kahoots and is opening an office in the city. The customer data from Kahoots, a rental marketing technology startup founded in 2006, will be integrated into the RentJuice platform, which offers … Continue reading “RentJuice Gets Kahoots”
Category: Boston
Skyhook Scores Sony Deal
Boston-based Skyhook Wireless announced this week that its location-finding technology will be embedded in Sony Computer Entertainment’s forthcoming “NGP” handheld gaming system, which will roll out in late 2011. Financial terms of the agreement were not disclosed, but the news comes on the heels of some other recent customer wins for Skyhook, including Intel and … Continue reading “Skyhook Scores Sony Deal”
Report: Bain Capital Ventures Opening Bay Area Office
Boston-based Bain Capital Ventures is planning to open an office in Palo Alto, CA, according to a report in PE Hub. Managing director Ajay Agarwal and several associates will be relocating to Silicon Valley, and the firm plans to hire several senior executives in the area, the report says. BCV has not confirmed the news. … Continue reading “Report: Bain Capital Ventures Opening Bay Area Office”
With Sanofi Buyout of Genzyme, Rare Disease Execs Upbeat About Interest in Their Niche
Speculation raged for months about the potential impacts of a Sanofi-Aventis (NYSE: [[ticker:SNY]]) takeover of Genzyme (NASDAQ: [[ticker:GENZ]]). Yet now that the French drug giant and Cambridge, MA-based biotech company have agreed to terms of a $20.1 billion buyout, local players in the market for rare disease drugs are contemplating what Sanofi’s huge move into … Continue reading “With Sanofi Buyout of Genzyme, Rare Disease Execs Upbeat About Interest in Their Niche”
You Snooze, You Lose: 10 Boring Boston-Area Tech Companies That Are Actually Interesting
A friend recently complained that my tweets are often along the lines of, “Boring company raises X million dollars.” And this is a guy who works in the tech startup community. But, au contraire mon frère, they are only boring if you don’t know the stories behind the companies and their deals. The tales of … Continue reading “You Snooze, You Lose: 10 Boring Boston-Area Tech Companies That Are Actually Interesting”
Does an Innovation Ecosystem Need an “MIT” or Will Evita Perons Do?: A Romanian Tale
In my role at the head of the MIT Entrepreneurship Center, I have the great opportunity, at times, to travel the world and learn about entrepreneurship on a global scale, and to gain knowledge and perspective to help us be more effective in our mission at home. This past week was such an experience. There … Continue reading “Does an Innovation Ecosystem Need an “MIT” or Will Evita Perons Do?: A Romanian Tale”
Rapid7 Secures $150,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=91aba3e9-dac9-4d4b-bf2c-0bb3f08a6d07&Preview=1 Date 3/3/2011 Company Name Rapid7 Mailing Address 545 Boylston Street Boston, ME 02116 Company Description Rapid7 is the leading provider of NeXpose Unified Vulnerability Management (UVM) Solutions. Website http://www.rapid7.com Transaction Type Venture Equity Transaction Amount $150,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing. M&A Terms … Continue reading “Rapid7 Secures $150,000 New Funding”
Ruckus Media Group Receives $3,500,000 Series A Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0fa19dd2-19a2-4b3b-aae0-2298f271b83d&Preview=1 Date 3/3/2011 Company Name Ruckus Media Group Mailing Address 488 Main Ave. Norwalk, CT 06851 Company Description Ruckus Mobile Media, an independent mobile family entertainment company, introduces traditional storytelling for today’s ways of telling stories by creating applications for mobile devices that entertain toddlers to teens from their fingers to their … Continue reading “Ruckus Media Group Receives $3,500,000 Series A Funding”
Baker Joins General Catalyst As EIR
Former Massachusetts Republican gubernatorial candidate Charlie Baker will join Cambridge, MA-based venture capital firm General Catalyst Partners as an executive in residence, he revealed in an e-mail to his supporters today. “I’ll be working with them to identify small and mid-size firms—primarily in the health care world—that the firm can partner with and help succeed,” … Continue reading “Baker Joins General Catalyst As EIR”
FDA Wants More Data on Merck KGaA’s MS Pill As Biogen Develops Rival Therapy
One of Biogen Idec’s rivals in the development of oral multiple sclerosis drugs got some bad news from the FDA. The agency has informed Germany-based Merck KGaA that it wants more safety data on the firm’s experimental MS pill cladribine, which has failed to gain approval at this time, the company said today. This news … Continue reading “FDA Wants More Data on Merck KGaA’s MS Pill As Biogen Develops Rival Therapy”
Experience.com’s New Technology Uses Online Dating-Style Surveys to Better Match Job Seekers to Positions
Boston-based Experience.com has long targeted the entry level job market with its career search software, and is now taking the data it’s gathered for over 15 years to more intelligently match employers and potential hires. CEO and founder Jenny Floren says the new technology, called Proactive Post, is looking to pull personal qualities and life … Continue reading “Experience.com’s New Technology Uses Online Dating-Style Surveys to Better Match Job Seekers to Positions”
CHiL Bought by International Rectifier, DynamicOps Gets $11M, NeuroPhage Raises $12M, & More Boston-Area Deals News
This week we’ve seen financings and acquisitions news spanning the life sciences, IT, and cleantech sectors in New England. —OpenMile, a Boston- and Chicago-based developer of Web and mobile technology for optimizing shipping, said it raised $6 million in a Series B deal led by Globespan Capital Partners, with participation from existing investor Charles River … Continue reading “CHiL Bought by International Rectifier, DynamicOps Gets $11M, NeuroPhage Raises $12M, & More Boston-Area Deals News”
RentJuice Acquires Kahoots for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=be449c0f-1bec-42f0-934c-7cc9c1ff8936&Preview=1 Date 3/2/2011 Company Name Kahoots Mailing Address Undisclosed Boston, MA 02451 Company Description The company has created an online platform that connects prospective renters, brokers and property managers. Website http://www.kahoots.biz Transaction Type M&A Transaction Amount Undisclosed Transaction Round Proceeds Purposes M&A Terms Financial terms of the transaction were not disclosed.
Aircuity Adds $1M
Newton, MA-based Aircuity, a maker of an air ventilation control system called OptiNet, has added another $1 million to its most recent equity funding round, bring the financing’s total to $3.5 million of a targeted $10 million round, according to an SEC document. The filing notes that the money comes from a total of seven … Continue reading “Aircuity Adds $1M”
Sproxil Grabs $1.8M
Sproxil, a provider of a mobile authentication system for identifying counterfeit medicine in developing countries, has brought in $1.8 million in equity funding from one investor, according to an SEC filing. The firm, which started in Somerville, MA, in 2009, first hit our radar when it won IBM’s SmartCamp competition last summer, and has participated … Continue reading “Sproxil Grabs $1.8M”
$6.6M for Cardiorobotics
Cardiorobotics, a developer of a robotic catheter for heart procedures, has raised $6.6 million of a planned $12.5 million round of equity and rights financing, according to an SEC filing. The firm lists a Raynham, MA, address. Xconomy wrote about the firm’s “snake” robotics platform in 2009, after the company took in $11.6 million in … Continue reading “$6.6M for Cardiorobotics”
Mello’s RXi Pharma to Raise $8.1M
RXi Pharmaceuticals (NASDAQ:[[ticker:RXII]]), a Worcester, MA-based biotech focused on RNA interference treatments, has priced a public offering of common stock and warrants expected to gross $8.1 million, according to a press release. The company, whose big-named scientific advisor is RNAi luminary and Nobel laureate Craig Mello, says that the public offering is expected to close … Continue reading “Mello’s RXi Pharma to Raise $8.1M”
NeuroPhage Nets $12.4M to Tackle Alzheimer’s and Other Brain Disorders
Score one for neurodegenerative disease therapies. Cambridge, MA-based NeuroPhage Pharmaceuticals said today it has closed $12.4 million in Series B financing led by Mérieux Développement, the healthcare investment arm of French firm Institut Mérieux. Irish biopharma Shire (NASDAQ: [[ticker:SHPGY]]) also participated in the round as a new investor. This is the first round of institutional … Continue reading “NeuroPhage Nets $12.4M to Tackle Alzheimer’s and Other Brain Disorders”
Agrivida, Developer of Cheap Biofuel Tech, Seeks Deals to Broaden Commercial Horizons
Agrivida scientists plan to be at an event this week supported by the U.S. Department of Energy in the Washington, DC, area, where the startup will show industry leaders its way of providing cheap sugar for making cellulosic biofuels and chemicals. The Medford, MA-based firm has been on somewhat of a roll as of late. … Continue reading “Agrivida, Developer of Cheap Biofuel Tech, Seeks Deals to Broaden Commercial Horizons”
Mzinga Nabs New CEO, Alan Nugent, to Raise Its Game in Social Business Software
Some more activity is bubbling up in social software for businesses. Mzinga, a social software firm based in Waltham, MA, is announcing today it has hired a prominent techie, Alan Nugent, as its new CEO. He succeeds former chief executive Barry Libert, Mzinga’s co-founder and chairman. (Former co-CEO Rick Faulk left the company in 2009 … Continue reading “Mzinga Nabs New CEO, Alan Nugent, to Raise Its Game in Social Business Software”
Sproxil Garners $1,789,999 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e83f28bb-32f9-442b-b54c-1bc250bde6b6&Preview=1 Date 3/1/2011 Company Name Sproxil Mailing Address 1 Fitchburg Street Somerville, MA 02143 Company Description The company provides a mobile authentication system for identifying counterfeit medicine in developing countries. Website http://www.sproxil.com Transaction Type Venture Equity Transaction Amount $1,789,999 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing. … Continue reading “Sproxil Garners $1,789,999 New Financing”
NeuroPhage Pharmaceuticals Garners $12,400,000 Series B Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ad05020f-0c6a-45f6-9111-8c4c2cb69ca4&Preview=1 Date 3/1/2011 Company Name NeuroPhage Pharmaceuticals Mailing Address 222 3rd St. Cambridge, MA 02142 Company Description NeuroPhage is developing a breakthrough protein dissaggregation platform for treatment of neurodegenerative diseases. Our lead Alzheimer’s disease (AD) drug candidate, NPT001, safely and effectively dissaggregates existing Aß plaque in preclinical animal models, which is unique … Continue reading “NeuroPhage Pharmaceuticals Garners $12,400,000 Series B Financing”
1366 Technologies Obtains $8,400,000 Series B Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c43ec93c-900b-461c-88a5-bb565bde85da&Preview=1 Date 3/1/2011 Company Name 1366 Technologies Mailing Address 45 Hartwell Avenue North Lexington, MA 02421 Company Description 1366 Technologies is making silicon solar cells competitive with coal. Our goal is to build on the success of multi-crystalline solar cells and manufacturing capacity to accelerate the transition to solar. Our products and … Continue reading “1366 Technologies Obtains $8,400,000 Series B Financing Round”
Verenium Names New CEO as it Consolidates in San Diego
Verenium (NASDAQ: [[ticker:VRNM]]), the biofuels developer that sold its cellulosic biofuels business to BP last summer, says CEO Carlos Riva plans to retire at the end of March, as the Cambridge, MA-based company consolidates its operations in San Diego. In a statement today, Verenium says Executive VP and CFO James Levine will succeed Riva as … Continue reading “Verenium Names New CEO as it Consolidates in San Diego”
WEST: Inside Venture Capital—Panel Discussion
At this event, put on by Women Entrepreneurs in Science and Technology, investors will discuss they look for in companies, and best ways for entrepreneurs to pitch. Speakers hail from firms such as MedImmune Ventures, Hercules Technology Growth Capital, and Sanofi-Aventis. Register here.
MIT Sloan BioInnovations Conference
Executives, investors, and academics the Massachusetts biotech field will gather at this all-day event. Speakers come from firms including Ironwood Pharmaceuticals, Philips Healthcare, and Ariad Pharmaceuticals, and panels will cover topics such as the R&D process, regulatory challenges, and emerging markets. Register online here.
MIT Enterprise Forum March Startup Clinic with Media Armour and The Immersion Project
This installment of the MIT Enterprise Forum’s Startup Clinic series of events has a big mobile focus. Media Armor, an analytics firm tracking the effect of mobile banner ads on consumers, will be represented alongside The Immersion Project, a mobile platform for sharing travel experiences. Sign up for this event here.
MIT Sloan Business in Gaming Conference
This full-day event will take a look at the slice of the Massachusetts economy driving by gaming, including console, online, social, and mobile games. Panels topics include gaming entrepreneurs, analytics, educational games, and the state’s role in supporting the industry. Register here.
CriticalMass, a Venture-Backed Co-Working Space for Startups, to Open at CIC
Boston has MassChallenge. Now Cambridge has CriticalMass. If nothing else, this will help fan the flames of the budding Boston-Cambridge startup incubator/real estate rivalry. (OK, we’ll keep an eye on New York and Silicon Valley, too.) The New England Venture Capital Association (NEVCA) and five Boston-area VC firms have banded together to organize what they … Continue reading “CriticalMass, a Venture-Backed Co-Working Space for Startups, to Open at CIC”
New Crimson Hexagon CEO Looking to Expand Analytics Services to Mobile, Target Life Sciences and Financial Services Clients
Cambridge, MA-based Crimson Hexagon is looking to new leadership to find additional markets for its sentiment analysis technology, which is designed to help companies get a better understanding of what’s being said about them in real-time on the Web. On Wednesday, the 15-person company announced it had brought on a new president and CEO, Patricia … Continue reading “New Crimson Hexagon CEO Looking to Expand Analytics Services to Mobile, Target Life Sciences and Financial Services Clients”
CHiL Semiconductor Acquired for $75M by International Rectifier
OK, this deal wins the award for clunkiest company names—but it’s an important exit for a Boston-area startup in a tough market. CHiL Semiconductor, based in Tewksbury, MA, confirmed today it is being acquired by International Rectifier (NYSE: [[ticker:IRF]]), based in the Los Angeles area, for $75 million in cash. The deal is expected to … Continue reading “CHiL Semiconductor Acquired for $75M by International Rectifier”
Diagnostics For All Gets $3M from Gates, UK
Boston-based nonprofit firm Diagnostics For All announced today that it has nabbed a $3 million grant from the Bill & Melinda Gates Foundation and the UK’s Department for International Development, to put toward developing three diagnostic tests for the agriculture space. The firm will use its diagnostics platform to develop a test for detecting milk … Continue reading “Diagnostics For All Gets $3M from Gates, UK”
Big Pharma’s Hardball Tactics Won’t Kill Biotech, But They Could Kill Off Some Pharmas
Few people in biotech have the guts to stir the pot the way Kevin Kinsella did in an interview with Xconomy’s Bruce Bigelow earlier this month. Kinsella, a venture capitalist with a 30-year track record of biotech investing, delivered a blistering analysis of what he sees as the pharmaceutical industry’s bad-faith negotiating habits, predatory behavior, … Continue reading “Big Pharma’s Hardball Tactics Won’t Kill Biotech, But They Could Kill Off Some Pharmas”
Swipely Shifts Social Shopping Business, Turning Credit Cards Into Loyalty Cards
Providence, RI-based Swipely is announcing today that it’s making a move in how its technology enables consumers to interact with their credit cards. Last summer the startup launched a service that allowed consumers to tell their social networks about and review the purchases they made on their credit and debit cards, but CEO and founder … Continue reading “Swipely Shifts Social Shopping Business, Turning Credit Cards Into Loyalty Cards”
DynamicOps Garners $11,000,000 Series B Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b955101a-3588-4713-a195-936c6a31a5d0&Preview=1 Date 2/28/2011 Company Name DynamicOps Mailing Address One Wall Street Floor 2 Burlington, MA 01803 Company Description DynamicOps solutions transform the way cloud and virtual desktop infrastructure environments are managed so that organizations can quickly respond to and capitalize on market changes. Website http://www.dynamicops.com Transaction Type Venture Equity Transaction Amount $11,000,000 … Continue reading “DynamicOps Garners $11,000,000 Series B Financing Round”
International Rectifier Acquires CHiL Semiconductor for $75,000,000
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=809e4ca8-9659-4416-bc80-9f6327738768&Preview=1 Date 2/28/2011 Company Name CHiL Semiconductor Mailing Address One Highwood Drive Tewskbury, MA 01876 Company Description CHiL Semiconductor Corp. is a fabless semiconductor company that designs, develops and markets intelligent mixed-signal semiconductors for the power management market, implementing unique digital control and striving to create energy efficient solutions. Website http://www.chilsemi.com Transaction … Continue reading “International Rectifier Acquires CHiL Semiconductor for $75,000,000”
SciFluor Life Sciences Lands $5,000,000 Series A Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=22b2054e-1bc9-4431-8c73-46ec52de571f&Preview=1 Date 2/28/2011 Company Name SciFluor Life Sciences Mailing Address 33 Arch St. Boston, MA 02110 Company Description The company’s late-stage fluorination technology is licensed exclusively from Harvard University. SciFluor’s technology enables end-stage or any-stage fluorination of a wide variety of organic compounds. Our technology and our library of fluorinated analogs are … Continue reading “SciFluor Life Sciences Lands $5,000,000 Series A Round”
MineralTree Receives $1,500,000 Series A Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5a46a882-9f1f-48ac-8639-a8424815d9d0&Preview=1 Date 2/28/2011 Company Name MineralTree Mailing Address 470 Atlantic Avenue 12th Floor Boston, MA 02210 Company Description MineralTree is a venture-backed software company based in Boston, Massachusetts. The company’s leadership team has a long track record of creating innovative new technology-based solutions to long-standing problems in banking and financial services. Website … Continue reading “MineralTree Receives $1,500,000 Series A Funding Round”
CardioFocus Finds $30.6M for Atrial Fibrillation Treatment
[Updated—03/01/11, 8:30 am ET] Investors have been getting behind a Marlborough, MA-based firm that is working on a potentially better way to treat an irregular heart rhythm known as atrial fibrillation. CardioFocus has raised $30.6 million in private financing, according to a press release. CardioFocus says that the round included new investors First Alliance & … Continue reading “CardioFocus Finds $30.6M for Atrial Fibrillation Treatment”
DynamicOps Grabs $11.3M
DynamicOps, a Burlington, MA-based company spun out by Credit Suisse in 2008 to commercialize its software for virtualizing IT environments, has brought in $11.3 million in equity-based funding from three investors, according to an SEC filing. The startup, which has distribution agreements with Dell and HP, builds public and private cloud infrastructures and virtual desktop … Continue reading “DynamicOps Grabs $11.3M”
Seven Questions That Will Decide Mobile’s Future-Part Two
To me, one thing seems pretty clear: the changes wrought over the coming 10 years by mobile devices are going to be even more far-reaching than those we’ve seen over the past 20 years from desktop and laptop PCs. The shifts in the ways we communicate, learn, shop, travel, and do business might not be … Continue reading “Seven Questions That Will Decide Mobile’s Future-Part Two”
Bluespec Brings In $1M
Waltham, MA-based Bluespec, a maker of software for designing electronics components, has raised $1 million in an equity offering, an SEC filing revealed. The company was founded in 2003 and had previously raised a total of $17.25 million, from investors Atlas Venture and North Bridge Venture Partners, according to its website. The filing for the … Continue reading “Bluespec Brings In $1M”
Genzyme Rival Fails to Get FDA Approval
The FDA has given a complete response letter to Israel-based Protalix Biotherapeutics for the company’s application for marketing approval of an protein therapy for Gaucher’s disease, the firm announced this morning. Cambridge, MA-based Genzyme currently has the best selling treatment for Gaucher’s disease, which is a rare genetic disorder that causes a fatty substance to … Continue reading “Genzyme Rival Fails to Get FDA Approval”
ImmunoGen CEO Highlights Two New Souped-Up Antibodies Against Cancer
ImmunoGen, in the eyes of Wall Street, is largely defined by one thing—its relationship with industry giant Genentech. That’s because Genentech uses ImmunoGen’s technology to help amp up the antibody trastuzumab (Herceptin) into a more potent breast cancer drug called T-DM1, which has shown significant promise in clinical trials. Yet ImmunoGen chief executive Daniel Junius … Continue reading “ImmunoGen CEO Highlights Two New Souped-Up Antibodies Against Cancer”
Vertex, Heartland Moves Call Attention To Boston-Cambridge Rivalry
Boston has been vocal about its intent to transform its Seaport District into an “innovation district” for fueling job creation and attracting cutting-edge companies. Just last month, the city’s odds of making this vision a reality seem to improve, with the news that two Cambridge, MA-based companies—Vertex Pharmaceuticals (NASDAQ: [[ticker:VRTX]]) and Heartland Robotics—would be relocating … Continue reading “Vertex, Heartland Moves Call Attention To Boston-Cambridge Rivalry”
Quanterix Partners With Novartis, Athenahealth and Microsoft Sync Up, Vertex Nails Clinical Trial, & More Boston-Area Life Sciences News
—Cambridge, MA-based Quanterix partnered up with Novartis Diagnostics, the unit of healthcare giant Novartis that tests the safety of 80 percent of the U.S. blood supply. Novartis will run tests to see how effective Quanterix’s device is at pinpointing a protein biomarker in the blood that is linked to an undisclosed neurological disorder. Terms of … Continue reading “Quanterix Partners With Novartis, Athenahealth and Microsoft Sync Up, Vertex Nails Clinical Trial, & More Boston-Area Life Sciences News”
Aircuity Garners $3,499,988 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1849a8b4-b5c4-421c-9b90-13d0e89dad17&Preview=1 Date 2/25/2011 Company Name Aircuity Mailing Address 39 Chapel Street Newton, MA 02458 Company Description Aircuity is the leading manufacturer of integrated sensing and control solutions that cost-effectively reduce building energy and operating expenses while simultaneously improving its indoor environmental quality. Website http://www.aircuity.com Transaction Type Venture Equity Transaction Amount $3,499,988 Transaction … Continue reading “Aircuity Garners $3,499,988 New Financing Round”
CardioFocus Lands $13,639,082 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f79b9030-f6fc-458b-8048-14f67eda0092&Preview=1 Date 2/25/2011 Company Name CardioFocus Mailing Address 500 Nickerson Road Marlborough, MA 01752 Company Description CardioFocus, Inc. is a privately held medical device company based in Maynard, Massachusetts. The company is developing, manufacturing and marketing proprietary, disposable fiber optic catheters for the visualization of the cardiac anatomy and the treatment of … Continue reading “CardioFocus Lands $13,639,082 New Financing Round”
Gearing Up for Mobile Madness on March 9: Top Themes to Watch
Mobile is becoming redundant: in technology, everything is mobile. It’s not just location-based services, or devices, or advertising—it’s networks, consumer Web apps, business software, social commerce, human-computer interfaces, you name it. Every company and every tech entrepreneur is touched by this revolution. That’s part of why the future of mobile is so exciting—and so very … Continue reading “Gearing Up for Mobile Madness on March 9: Top Themes to Watch”
Thermo Fisher Selling Units for $940M
Waltham, MA-based Thermo Fisher Scientific (NYSE:[[ticker:TMO]]) says it has inked deals to sell its Athena Diagnostics and Lancaster Laboratories businesses for a total of $940 million in cash to boost shareholder value. Details about Thermo Fisher’s plans to sell the businesses were leaked to the press last month. Madison, NJ-based lab testing giant Quest Diagnostics … Continue reading “Thermo Fisher Selling Units for $940M”